Novo Nordisk
NVO
#35
Rank
HK$2.178 T
Marketcap
HK$483.99
Share price
1.76%
Change (1 day)
-51.97%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): HK$147.58 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$41.89 Billion. , an increase over its 2023 earnings that were of HK$119.71 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 HK$146.95 B22.75%
2023 HK$119.71 B57.64%
2022 HK$75.94 B5.35%
2021 HK$72.08 B12.47%
2020 HK$64.09 B13.07%
2019 HK$56.68 B-3.35%
2018 HK$58.65 B1.79%
2017 HK$57.61 B4.52%
2016 HK$55.12 B9.42%
2015 HK$50.38 B8.24%
2014 HK$46.54 B3.45%
2013 HK$44.99 B19.02%
2012 HK$37.80 B15.21%
2011 HK$32.81 B17.71%
2010 HK$27.87 B24.78%
2009 HK$22.34 B10.62%
2008 HK$20.19 B55.97%
2007 HK$12.94 B7.07%
2006 HK$12.09 B18.18%
2005 HK$10.23 B11.33%
2004 HK$9.19 B
2002 HK$5.96 B-14.39%
2001 HK$6.96 B-52.82%
2000 HK$14.75 B250%
1999 HK$4.21 B31.21%
1998 HK$3.21 B34.31%
1997 HK$2.39 B11.46%
1996 HK$2.14 B9.03%
1995 HK$1.96 B-3.15%
1994 HK$2.03 B-0.67%
1993 HK$2.04 B45.38%
1992 HK$1.40 B-13.81%
1991 HK$1.63 B37.12%
1990 HK$1.19 B-0.79%
1989 HK$1.20 B26.2%
1988 HK$0.95 B24.97%
1987 HK$0.76 B-0.9%
1986 HK$0.76 B-7.78%
1985 HK$0.83 B24.87%
1984 HK$0.66 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$86.22 B-41.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$98.38 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$65.02 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$61.62 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France